Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A. Forastiere, Gregory T. Wolf, Jan S. Lewin et al.|Journal of Clinical Oncology|2017Cited by 366
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in <i>TP53</i> mutant head and neck squamous cell carcinoma (HNSCC)Md Maksudul Alam, Cherie‐Ann O. Nathan|Oncotarget|2023Cited by 18